markets

In recent months, Janus Henderson’s Forty Fund highlighted Madrigal Pharmaceuticals’ success with Rezdiffra, the first FDA-approved MASH therapy,…

Apple exporters in Europe are…

(Alliance News) – The Bank of Italy has further tightened its oversight of BFF Bank. An ongoing inspection…

Wall Street is starting the new week on a clearly positive note. Major indexes are rising, and risk…

Chinese tech giant JD.com is responding to new hurdles in its acquisition of Ceconomy by refiling its application…

Published on 30/03/2026 – 9:39 GMT+2•Updated 9:43 Europe’s fisheries and aquaculture sectors are facing growing strain from geopolitical…

Why ACI Worldwide (ACIW) Is On Investors’ Radar Today ACI Worldwide (ACIW) is drawing attention after recent share…

After after the US captured Venezuelan President Nicolas Maduro, Signum Global Advisors chairman and founder Charles Myers saw…

European shares showed little movement on Monday as investors awaited crucial local inflation data while keeping a…

1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Avoid Wall Street is overwhelmingly…

Published on 30/03/2026 – 7:07 GMT+2•Updated 8:29 European markets are set to open lower on Monday, with futures…

Recent analyst reports around Tyler Technologies (TYL) ahead of its upcoming fiscal first quarter 2026 earnings and June…

Why Madrigal Pharmaceuticals (MDGL) Is Up 14.1% After Expanding Its MASH Franchise Beyond Rezdiffra